Study of Cannabidiol in Sanfilippo Syndrome

NCT06333041 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Sanfilippo Syndrome
Mucopolysaccharidosis III

Interventions

DRUG: Epidiolex
DRUG: Placebo

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center